| Monocrystalline iron oxide nanocompounds (MION): physicochemical properties T Shen, R Weissleder, M Papisov, A Bogdanov Jr, TJ Brady Magnetic Resonance in Medicine 29 (5), 599-604, 1993 | 689 | 1993 |
| Poly (ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity VP Torchilin, VG Omelyanenko, MI Papisov, AA Bogdanov Jr, ... Biochimica et Biophysica Acta (BBA)-Biomembranes 1195 (1), 11-20, 1994 | 679 | 1994 |
| Long-circulating iron oxides for MR imaging R Weissleder, A Bogdanov, EA Neuwelt, M Papisov Advanced Drug Delivery Reviews 16 (2-3), 321-334, 1995 | 553 | 1995 |
| A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. AA Bogdanov Jr, R Weissleder, HW Frank, AV Bogdanova, N Nossif, ... Radiology 187 (3), 701-706, 1993 | 272 | 1993 |
| Why do polyethylene glycol-coated liposomes circulate so long?: Molecular mechanism of liposome steric protection with polyethylene glycol: Role of polymer chain flexibility VP Torchilinl, MI Papisov Journal of liposome research 4 (1), 725-739, 1994 | 261 | 1994 |
| MR lymphography: study of a high-efficiency lymphotrophic agent. R Weissleder, JF Heautot, BK Schaffer, N Nossiff, MI Papisov, ... Radiology 191 (1), 225-230, 1994 | 167 | 1994 |
| Colloidal magnetic resonance contrast agents: effect of particle surface on biodistribution MI Papisov, A Bogdanov Jr, B Schaffer, N Nossiff, T Shen, R Weissleder, ... Journal of Magnetism and Magnetic Materials 122 (1-3), 383-386, 1993 | 166 | 1993 |
| CNS penetration of intrathecal-lumbar idursulfase in the monkey, dog and mouse: implications for neurological outcomes of lysosomal storage disorder P Calias, M Papisov, J Pan, N Savioli, V Belov, Y Huang, J Lotterhand, ... PloS one 7 (1), e30341, 2012 | 143 | 2012 |
| Theoretical considerations of RES-avoiding liposomes: molecular mechanics and chemistry of liposome interactions MI Papisov Advanced drug delivery reviews 32 (1-2), 119-138, 1998 | 136 | 1998 |
| Physiology of the intrathecal bolus: the leptomeningeal route for macromolecule and particle delivery to CNS MI Papisov, VV Belov, KS Gannon Molecular pharmaceutics 10 (5), 1522-1532, 2013 | 101 | 2013 |
| Pharmaceutical iron oxides for MR imaging R Weissleder, M Papisov Rev Magn Reson Med 4, 1-20, 1992 | 97 | 1992 |
| In vivo degradation of silicones L Garrido, B Pfleiderer, M Papisov, JL Ackerman Magnetic resonance in medicine 29 (6), 839-843, 1993 | 95 | 1993 |
| Drug targeting in magnetic resonance imaging. R Weissleder, A Bogdanov, M Papisov Magnetic Resonance Quarterly 8 (1), 55-63, 1992 | 86 | 1992 |
| MR Lymphography with a Lymphotropic T1‐Type MR Contrast Agent: Gd‐DTPA‐PGM L Harika, R Weissleder, K Poss, C Zimmer, MI Papisov, TJ Brady Magnetic resonance in medicine 33 (1), 88-92, 1995 | 81 | 1995 |
| Targeted delivery of diagnostic agents by surface-modified liposomes VP Torchilin, VS Trubetskoy, AM Milshteyn, J Canillo, GL Wolf, MI Papisov, ... Advances in Drug Delivery Systems, 6, 45-58, 1994 | 79 | 1994 |
| MION-ASF: biokinetics of an MR receptor agent BK Schaffer, C Linker, M Papisov, E Tsai, N Nossiff, T Shibata, ... Magnetic resonance imaging 11 (3), 411-417, 1993 | 77 | 1993 |
| System of drug delivery to the lymphatic tissues MI Papisov, TJ Brady US Patent 5,582,172, 1996 | 71 | 1996 |
| Conjugates comprising a biodegradable polymer and uses therefor DR Elmaleh, SC Robson, ML Papisov US Patent 7,785,618, 2010 | 69 | 2010 |
| Biodegradable polyacetal polymers and methods for their formation and use MI Papisov US Patent 5,863,990, 1999 | 69 | 1999 |
| Macromolecular intravenous contrast agent for MR lymphography: characterization and efficacy studies. L Harika, R Weissleder, K Poss, MI Papisov Radiology 198 (2), 365-370, 1996 | 69 | 1996 |
